Question 1

What is the catalog number for Cyclic Pifithrin-α hydrobromide?

Accepted Answer

The catalog number for Cyclic Pifithrin-α hydrobromide is C11354.

Question 2

What sizes are available for Cyclic Pifithrin-α hydrobromide?

Accepted Answer

Cyclic Pifithrin-α hydrobromide is available in the following size(s): 10 mg, 25 mg.

Question 3

How many pack sizes does Cyclic Pifithrin-α hydrobromide come in?

Accepted Answer

Cyclic Pifithrin-α hydrobromide is available in 2 different pack sizes.

Question 4

Is Cyclic Pifithrin-α hydrobromide in stock?

Accepted Answer

Cyclic Pifithrin-α hydrobromide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Cyclic Pifithrin-α hydrobromide

Product Specifications

CAS Number

SKU

Target

Applications

Smiles

Molecular Formula

Additionnal Information

Storage Conditions

Available Sizes

Frequently Asked Questions

Explore Other Products

DL-threo-Ritalinic Acid-d10

DL-threo-Ritalinic Acid-d10

DL-threo-Ritalinic Acid-d10

Human Cathepsin V ELISA Kit

Lentiviral human PAIP2 shRNA (UAS) - Lentiviral human PAIP2 shRNA (UAS, GFP) (25)

Anticancer agent 101